Friday, April 30, 2010

NeurogesX Gets $40M In Royalty Financing

San Mateo-based NeurogesX, a biopharmaceuticals firm focused on pain management, said today that it has entered into a $40M royalty financing agreement, from Cowen Healthcare Royalty Partners, L.P. According to the firm, the debt funding will be secured by royalties and milestone payments that the firm has with Astellas Pharma Europe Ltd.